|
C2ORF34 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.143800E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.523500E-03 |
| Normal-vs-Stage2 |
2.137100E-03 |
| Normal-vs-Stage3 |
2.107900E-02 |
| Normal-vs-Stage4 |
5.085000E-01 |
| Stage1-vs-Stage2 |
3.454600E-01 |
| Stage1-vs-Stage3 |
9.052400E-01 |
| Stage1-vs-Stage4 |
1.749350E-01 |
| Stage2-vs-Stage3 |
5.262800E-01 |
| Stage2-vs-Stage4 |
9.456200E-02 |
| Stage3-vs-Stage4 |
2.941400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.075600E-03 |
| Normal-vs-AfricanAmerican |
1.007650E-02 |
| Normal-vs-Asian |
9.313600E-01 |
| Caucasian-vs-AfricanAmerican |
2.983600E-01 |
| Caucasian-vs-Asian |
3.281000E-01 |
| AfricanAmerican-vs-Asian |
2.071600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.337400E-03 |
| Normal-vs-Female |
6.441800E-03 |
| Male-vs-Female |
4.272800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.820700E-03 |
| Normal-vs-Extreme_Weight |
3.082400E-03 |
| Normal-vs-Obese |
1.157600E-02 |
| Normal-vs-Extreme_Obese |
1.420400E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.364200E-01 |
| Normal_Weight-vs-Obese |
5.152000E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.703600E-01 |
| Extreme_Weight-vs-Obese |
4.746000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.529600E-01 |
| Obese-vs-Extreme_Obese |
9.366800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.461570E-02 |
| Normal-vs-Age(41-60Yrs) |
4.221800E-03 |
| Normal-vs-Age(61-80Yrs) |
4.182000E-03 |
| Normal-vs-Age(81-100Yrs) |
1.055410E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.914200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.563200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.226600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.576800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.181800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.235000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.103900E-03 |
| Normal-VS-Type2 PRCC |
5.476800E-03 |
| Normal-VS-KIRP CIMP |
2.293800E-02 |
| Normal-VS-Unclassified PRCC |
2.032200E-02 |
| Type1 PRCC-VS-Type2 PRCC |
9.512800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.127600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.751600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.756600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.045600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.754400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.367100E-04 |
| Normal-vs-N1 |
9.790300E-02 |
| Normal-vs-N2 |
1.279760E-01 |
| N0-vs-N1 |
1.801380E-01 |
| N0-vs-N2 |
7.862200E-01 |
| N1-vs-N2 |
4.135800E-01 |
|
|
